Barbara Ann Karmanos Cancer Institute
Clinical trials sponsored by Barbara Ann Karmanos Cancer Institute, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Diabetes drug could help rare kidney disease patients Results expected Apr 2027 (estimated)
- Could electromagnetic waves help shrink breast tumors before surgery? Results expected Apr 2027 (estimated)
- Could electromagnetic fields help fight breast cancer? Results expected May 2027 (estimated)
- Talking money with your oncologist: a new tool to ease Cancer's financial toll Results expected Jul 2027 (estimated)
- Personalized cancer care: genetic analysis may unlock targeted treatments for advanced lung cancer Results expected Jul 2027 (estimated)
-
New drug cocktail shows promise for Tough-to-Treat lymphomas
Disease control OngoingThis phase 2 trial tests whether adding polatuzumab vedotin to standard chemotherapy can improve outcomes for people with aggressive B-cell lymphomas, including double-hit and triple-hit types. Only 8 participants were enrolled, and the study focuses on safety and how many achiev…
Phase 2 • Sponsor: Barbara Ann Karmanos Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
New drug combo shows promise for tough lymphoma
Disease control OngoingThis study tests adding a drug called selinexor to the standard chemotherapy RCHOP for people with B-cell non-Hodgkin lymphoma. The goal is to find the safest dose and see if the combination works better than standard treatment alone. About 43 adults with advanced or returning ly…
Phase 1/2 • Sponsor: Barbara Ann Karmanos Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
Can a new tracer light up cancer growth?
Diagnosis OngoingThis trial is testing a new imaging tracer called FLT, which is used with a PET scan to measure how fast tumors are growing. The study includes people with various cancers or those awaiting a biopsy for a suspicious mass. The goal is to see if FLT PET imaging can help find and di…
Sponsor: Barbara Ann Karmanos Cancer Institute • Aim: Diagnosis
Last updated Aug 12, 2026 00:00 UTC
-
Talking money with your oncologist: a new tool to ease Cancer's financial toll
Symptom relief OngoingThis study tests a communication intervention designed to help oncology providers—like doctors, nurses, and social workers—discuss treatment costs with cancer patients. The goal is to reduce financial toxicity, the stress and hardship caused by medical expenses. Participants will…
Sponsor: Barbara Ann Karmanos Cancer Institute • Aim: Symptom relief
Last updated Aug 08, 2026 00:03 UTC
-
Personalized cancer care: genetic analysis may unlock targeted treatments for advanced lung cancer
Knowledge-focused OngoingThis trial investigates whether comprehensive genomic analysis of tumor tissue can help doctors choose targeted therapies for patients with advanced non-small cell lung cancer. Participants provide tumor samples (from past biopsies or new ones) for genetic testing. The goal is to…
Sponsor: Barbara Ann Karmanos Cancer Institute • Aim: Knowledge-focused
Last updated Jul 31, 2026 00:00 UTC